Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $233.72 Million |
|---|---|
| Enterprise Value | $232.38 Million |
| Earnings per Share | $-0.81 |
| Beta | 0.86 |
| Outstanding Shares | 19,807,000 |
| P/E Ratio | -5.77 |
|---|---|
| PEG | -939.35 |
| Price to Sales | - |
| Price to Book Ratio | -11.8 |
| Enterprise Value to Revenue | 24.89 |
| Enterprise Value to EBIT | -17.89 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | -1.84 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Adocia S.A. is a clinical-stage biotechnology firm that specializes in developing enhanced formulations of existing therapeutic proteins and peptides, primarily targeting diabetes and other metabolic disorders. The company leverages its ...